A proposed model for conducting institutional-specific cost-effectiveness analysis: a case study of lipid-lowering agents

MeSH terms

• Cost-Benefit Analysis / methods*
• Economics, Pharmaceutical
• Health Care Rationing
• Health Services Research / economics
• Health Services Research / methods*
• Humans
• Hypolipidemic Agents / therapeutic use*
• Models, Econometric*
• Pharmacy Service, Hospital / economics*
• United States